Research Carolina Elite

Denver, North Carolina 28078

5 studies enrolling now · 17 studies all time

What they study most

COVID-19, Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease (COPD), Chronic Uncontrolled Gout, Gout, Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 1 (NT 1), Narcolepsy Type 1 (NT1), Narcolepsy Type 2, OSA, Severe Postpartum Depression

Studies at this site

• A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout — Recruiting now
• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy — Recruiting now
• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
• A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Running, not enrolling
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
• Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1 — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD) — Completed
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19 — Stopped early
• A Study of TAK-994 in Adults With Narcolepsy — Stopped early